Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Recruiting 3Active not recruiting 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Carcinoma, Non-Small-Cell Lung 35Breast Neoplasms 27Prostatic Neoplasms 22Stomach Neoplasms 13Squamous Cell Carcinoma of Head and Neck 12Neoplasms 10Lung Neoplasms 10Urinary Bladder Neoplasms 8Head and Neck Neoplasms 8Triple Negative Breast Neoplasms 7Neoplasm Metastasis 7Carcinoma, Squamous Cell 6Non-Muscle Invasive Bladder Neoplasms 5Nasopharyngeal Carcinoma 5Carcinoma, Transitional Cell 5Adenocarcinoma 5Oropharyngeal Neoplasms 4Sarcoma 3Prostatic Neoplasms, Castration-Resistant 3Parkinson Disease 4, Autosomal Dominant Lewy Body 3Ovarian Neoplasms 3Metastatic Castration-resistant Prostate Cancer 3HER2-positive Breast Cancer 3Esophageal Squamous Cell Carcinoma 3Endometrial Neoplasms 3Anatomic Stage I Breast Cancer AJCC v8 3Vaccinia 2Recurrence 2Peritoneal Neoplasms 2Metastatic Castration-Resistant Prostate Cancer 2

Interventions

Specimen Handling 4Docetaxel 3pertuzumab 2pembrolizumab 2Trastuzumab 2Taxes 2Paclitaxel 2High-Energy Shock Waves 2Cyclophosphamide 2Carboplatin 2Biopsy 2trastuzumab biosimilar HLX02 1fisetin 1Watchful Waiting 1Surgical Procedures, Operative 1Simvastatin 1PF-05280014 1Ontruzant 1Ogivri 1Observation 1Minoxidil 1Methods 1Metformin 1Magnetic Resonance Spectroscopy 1Letrozole 1Immunoglobulin G 1Educational Status 1Early Intervention, Educational 1Doxorubicin 1Disulfides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Anatomic Stage I Breast Cancer AJCC v8 × Docetaxel × Clear all
NCT04329065 2026-05-19

Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer

University of Washington

Phase 2 Recruiting
25 enrolled
Breast

Anatomic Stage I Breast Cancer AJCC v8

NCT06042569 2026-04-17

Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial

City of Hope Medical Center

Phase 2 Recruiting
174 enrolled
Breast

Anatomic Stage I Breast Cancer AJCC v8

NCT05929768 2025-11-05

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

SWOG Cancer Research Network

Phase 3 Recruiting
2,400 enrolled
Breast

Anatomic Stage I Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡